These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32135275)

  • 1. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
    Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
    Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
    Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
    Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
    Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.
    Walscheid K; Heiligenhaus A; Holzinger D; Roth J; Heinz C; Tappeiner C; Kasper M; Foell D
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7653-60. PubMed ID: 26624497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
    Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
    Hinze CH; Foell D; Johnson AL; Spalding SJ; Gottlieb BS; Morris PW; Kimura Y; Onel K; Li SC; Grom AA; Taylor J; Brunner HI; Huggins JL; Nocton JJ; Haines KA; Edelheit BS; Shishov M; Jung LK; Williams CB; Tesher MS; Costanzo DM; Zemel LS; Dare JA; Passo MH; Ede KC; Olson JC; Cassidy EA; Griffin TA; Wagner-Weiner L; Weiss JE; Vogler LB; Rouster-Stevens KA; Beukelman T; Cron RQ; Kietz D; Schikler K; Mehta J; Ting TV; Verbsky JW; Eberhard AB; Huang B; Giannini EH; Lovell DJ
    Arthritis Rheumatol; 2019 Mar; 71(3):451-459. PubMed ID: 30225949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.
    Šumová B; Cerezo LA; Szczuková L; Nekvindová L; Uher M; Hulejová H; Moravcová R; Grigorian M; Pavelka K; Vencovský J; Šenolt L; Závada J
    Rheumatol Int; 2019 Mar; 39(3):469-478. PubMed ID: 30392117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.
    Thames BE; Barr JW; Suchodolski JS; Steiner JM; Heilmann RM
    J Vet Diagn Invest; 2019 Jul; 31(4):645-651. PubMed ID: 31170888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
    Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
    J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
    Wakiya R; Kameda T; Ueeda K; Nakashima S; Shimada H; Mansour MF; Kato M; Miyagi T; Miyatake N; Kadowaki N; Dobashi H
    Lupus; 2019 Jun; 28(7):826-833. PubMed ID: 31068068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.
    Aljaberi N; Tronconi E; Schulert G; Grom AA; Lovell DJ; Huggins JL; Henrickson M; Brunner HI
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):7. PubMed ID: 31948488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
    Smith EMD; Jorgensen AL; Beresford MW;
    Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of S100 calgranulin genes in peripheral blood mononuclear cells from patients with Takayasu arteritis.
    Kabeerdoss J; Thomas M; Goel R; Mohan H; Danda S; L J; Danda D
    Cytokine; 2019 Feb; 114():61-66. PubMed ID: 30594066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis.
    Hassan AM; Farghal NMA; Hegab DS; Mohamed WS; Abd-Elnabi HH
    Clin Rheumatol; 2018 Nov; 37(11):3025-3032. PubMed ID: 30006918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.